Flow Cytometry

Comprehensively Quantify Therapeutic Effects through High Throughput Flow Cytometry Analysis of Various Cell Types

Gain new insight into your drug mechanism of action and PD through robust and in-depth immunophenotyping. Maximize immunotherapeutic benefit, limit unwanted toxicities, and increase your chances of preclinical/clinical success through comprehensively characterizing cells of interest. Use our high quality flow cytometry data to better understand:

• The immune make-up of relevant organs such as tumor, blood, spleen, and lymph nodes
• Therapeutic effect on the frequencies and functionality of cell subsets
• Individual specimen variations and heterogeneity of response

Characterize Complex Immune-Phenotypes and Rare Cells of Interest with our Well-Established Flow Cytometry Platform

• Characterize cells in high throughput with limited sample volume enabled by Miltenyi gentleMACS™ Dissociators, state-of-the-art equipment including BD FACSCalibur™, BD Accuri™ C6, NovoCyte, Beckman Gallios, BD LSRFortessa™ and BD LSRFortessa X-20 (up to 17 colors) with 96-well plate HTS attachment
• Overcome tumor complexity with our pre-optimized list of over 20 protocols for tumor tissue dissociation and parent gating strategies
• Ensure accurate staining, processing, and gating with our stringent controls and manual compensation
• Eliminate human error through central data processing and analysis facilitated by data transfer software
• Gain expert guidance from our dedicated FACS team to help determine the right dissociation protocols, panel configurations, gating strategies, etc. for your study
• Modify reports to fit evolving needs with dynamic and informative reporting packages including a variety of raw data, statistical analyses, observations, actionable recommendations, data visualization, etc.
• Easily and securely review high quality data and reports through our cloud portal

Our standard flow cytometry panels have been validated in multiple oncology and inflammation in vivo models to provide basic to comprehensive analysis of lymphoid and myeloid cell populations. Models analyzed include syngeneics, tumor homografts (MuPrime™), human target expressing (HuGEMM™/HuCELL™), humanized, GvHD, and peritonitis models.

Customized panels are also available, which undergo thorough validation prior to running your samples. See our standard panels and gating strategy below.